The shares of Quotient Technology Inc. have increased by more than 9.36% this year alone. The shares recently went up by 17.35% or $1.9 and now trades at $12.85. The shares of Genesis Healthcare, Inc. (NYSE:GEN), has jumped by 54.67% year to date as of 02/14/2018. The shares currently trade at $1.18 and have been able to report a change of 20.41% over the past one week.
The stock of Quotient Technology Inc. and Genesis Healthcare, Inc. were two of the most active stocks on Wednesday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.
Next 5Y EPS Growth: 20.00% versus 10.00%
When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that QUOT will grow it’s earning at a 20.00% annual rate in the next 5 years. This is in contrast to GEN which will have a positive growth at a 10.00% annual rate. This means that the higher growth rate of QUOT implies a greater potential for capital appreciation over the years.
Profitability and Returns
Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. The ROI of QUOT is -6.40% while that of GEN is 8.90%. These figures suggest that GEN ventures generate a higher ROI than that of QUOT.
The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, QUOT’s free cash flow per share is a positive 0.01, while that of GEN is negative -0.46.
Liquidity and Financial Risk
The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for QUOT is 3.90 and that of GEN is 0.20. This implies that it is easier for QUOT to cover its immediate obligations over the next 12 months than GEN.
QUOT currently trades at a forward P/E of 24.81, a P/B of 3.39, and a P/S of 3.99 while GEN trades at a P/S of 0.04. This means that looking at the earnings, book values and sales basis, QUOT is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.
Analyst Price Targets and Opinions
The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of QUOT is currently at a -30.54% to its one-year price target of 18.50. Looking at its rival pricing, GEN is at a -59.31% relative to its price target of 2.90. This figure implies that over the next one year, GEN is a better investment.
When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), QUOT is given a 1.10 while 3.00 placed for GEN. This means that analysts are more bullish on the outlook for GEN stocks.
Insider Activity and Investor Sentiment
Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for QUOT is 8.03 while that of GEN is just 6.94. This means that analysts are more bullish on the forecast for GEN stock.
The stock of Quotient Technology Inc. defeats that of Genesis Healthcare, Inc. when the two are compared, with QUOT taking 6 out of the total factors that were been considered. QUOT happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, QUOT is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for QUOT is better on when it is viewed on short interest.